Immuno-Oncology

The immune therapy program will make cutting edge contributions to the field of immune-oncology by uncovering novel findings in basic and translational research, as well as learning from patient responses in clinical trials to improve response rates and quality of life. Our goal is also to develop novel technologies and reagents to remain at the forefront of this field.

 

Scientist, Senior Scientist, Clinician Scientist

Hirano, Naoto (Chair)

Brooks, David

Mak, Tak W

McGaha, Tracy

Ohashi, Pamela

Reedijk, Michael

 

Affiliate Scientist 

Sacher, Adrian

 

Emeritus Scientist 

Paige, Christopher

 

Staff Scientist 

Nguyen, Linh

 

Clinical Champion

Gerbitz, Armin

Saibil, Sam